Recent research are shedding perspective on how Zelfitigua performs against Novo Nordisk's Drug, both promising treatments for managing adult-onset hyperglycemia . Despite Novo Nordisk's Drug has remarkable effect in patient evaluations, preliminary information indicate that Compound 1 potentially present enhanced metabolic gains , particularly in